Clorox Company (NYSE: CLX) Monthly Stock Report - October 12, 2025

Company Overview

The Clorox Company, established in 1913 and headquartered in Oakland, California, stands as a formidable player in the Household & Personal Products industry within the Consumer Defensive sector. The company manufactures and markets a diverse range of consumer and professional products across four main segments: Health and Wellness, Household, Lifestyle, and International. These segments encompass well-known brands such as Clorox, Glad, Burt's Bees, and Brita, with products available through various distribution channels including mass retailers, grocery outlets, and online platforms.

In a sector notorious for its stability, Clorox maintains a significant operational capacity, reporting total revenue of $7.1 billion, which underscores its competitive positioning in the market.

52-Week Price Performance Analysis

52-Week Price Performance Chart

The past year has witnessed significant volatility in Clorox's stock performance. Currently trading at $120.10, the stock has experienced a notable decline, down approximately 23.03% from its 52-week high of $171.37. A technical analysis of the 52-week stock price chart reveals a persistent bearish trend characterized by a downward-sloping trendline that has established a major resistance level around $160. This resistance has consistently defined the upper limit of price action since the highs observed in October and November.

Key price levels further delineate Clorox's trading dynamics: - Current Price: $120.10 - Support Level: Approximately $120, where the stock is currently testing - Major Resistance Level: $160 - Fifty-Day Moving Average: $122.40, indicating a downward inclination

Despite the slight consolidation around the $120 level, the stock has struggled to regain upward momentum, with lower highs and lower lows confirming a bearish trend. The absence of clear reversal patterns suggests that while support is currently holding, the trend could resume its downward trajectory if this level is breached. Investors should be vigilant for any breakouts above the moving average or trendline that could indicate a potential shift towards bullish momentum.

Financial Performance and Metrics

Clorox's recent financial performance has raised eyebrows, with key metrics indicating areas of both strength and concern. The company's total revenue of $7.1 billion signifies robust operational prowess; however, challenges loom as highlighted by a reported 7.7% year-over-year decline in net sales for its fiscal third quarter, specifically dropping to $1.67 billion, which fell short of analyst expectations. Adjusted earnings per share for the quarter stood at $1.45, noticeably below the forecast of $1.57.

The company's EBITDA of approximately $1.4 billion illustrates strong operational efficiency despite recent challenges. Analysts have set varying price targets, with a target high of $166.00 representing substantial upside potential, while the target mean price is set at approximately $130.76, allowing for a moderate expectation of growth.

Key Financial Metrics:

• Current Price: $120.10
• Total Revenue: $7.1 billion
• Adjusted EPS: $1.45 (Q3 Fiscal 2025)
• EBITDA: $1.4 billion
• Target High Price: $166.00
• Target Mean Price: $130.76

Recent News and Developments

Recent developments have unfortunately tempered investor sentiment regarding Clorox. The company made headlines following a notable 7.7% decline in net sales for its fiscal third quarter, forcing Clorox to adjust its annual sales outlook to a conservative estimate of either flat or a 1% decline.

In addition, a lawsuit filed in August 2025 against its IT service provider, Cognizant, has garnered attention. Clorox alleges that operational disruptions stemming from a significant ransomware attack in 2023 have incurred substantial financial losses. The company seeks $380 million in damages, which highlights potential vulnerabilities within its operational framework.

Additionally, reaching a 52-week low of $116.53 in September reflects the ongoing difficulties. The cautious analyst sentiment following these events has led to a consensus recommendation of "Hold" with a 12-month price target averaging $141.75, which implies a potential upside of approximately 17.65% from the current stock price.

Market Sentiment and Analyst Recommendations

The market sentiment surrounding Clorox appears cautious yet intrigued, as analyst opinions reflect a consensus recommendation of "Hold." The average recommendation score stands at 3.16 across 17 analysts, suggesting a balanced view of maintaining existing investments without advocating for new purchases given current market dynamics.

With Clorox's stock price located near its lower end of the trading range for the year, investor intrigue persists. Here's a quick summary of the market sentiment metrics:

• Current Price: $120.10
• 52-week High: $171.37
• 52-week Low: $116.53
• Consensus Recommendation: Hold
• Average Analyst Price Target: $141.75, indicating a potential upside of 17.65%.

Conclusion

Investors need to weigh both risks and opportunities when considering Clorox (NYSE: CLX) amidst the backdrop of its recent performance and external challenges. While solid fundamentals and a recognizable brand portfolio lend credibility, investor caution appears warranted due to recent market trends and performance setbacks.

In the current environment, retaining investments in Clorox may be a prudent choice as market dynamics continue to unfold. Nonetheless, investors should remain vigilant for potential bullish signals that might signify a favorable shift in the stock's trajectory.

As always, sound investment strategies necessitate continuous monitoring and adaptation to fluctuating market conditions.